HBSP (USA)
-
Cancer Screening in Japan: Market Research and Segmentation
Quelch, John A.; Rodriguez, MargaretCase HBS-514057-EMarketingSince founding CancerScan in 2008, Jun Fukuyoshi and Yoshiki Ishikawa had helped to improve cancer screening rates in Japan. Between 2005 and 2007, awareness of breast cancer in Japan rose from 55% to 70%, but the incidence of breast cancer screenings remained constant. Jun and Yoshiki applied marketing research techniques to increase the screening rate for breast cancer, a disease which killed over 12,000 Japanese women in 2011. Cancer screening...Starting at €8.20
-
Vision 2020: Takeda and the Vaccine Business
Quelch, John A.; Rodriguez, MargaretCase HBS-514084-EMarketingTo maximize their effectiveness, color cases should be printed in color. In 2014, Yasuchika Hasegawa was orchestrating the transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a Japanese heritage. A 33-year veteran of Takeda, Hasegawa-san was appointed president of Takeda in 2003 and chief executive in 2009. By 2013, Takeda was in the midst of implementing its new Vision 2020 plan, a s...Starting at €8.20
-
The Business of Pain: Johnson & Johnson and the Promise of Opioids (B)
Snowberg, Erik; Fetter, Trevor; Schulman, Amy W.Case HBS-720423-EBusiness Ethics and Corporate Social ResponsibilityThis case is designed to provide an engrossing overview of stakeholder capitalism through a vigorous discussion of the conflicts that can arise when trying to serve multiple stakeholders. In 2007, Johnson & Johnson's (J&J) subsidiary Janssen has to decide whether or not to launch a new opioid painkiller-the first such launch in 25 years-amidst growing concerns about opioid abuse in the U.S. The (A) case starts with the history of human interactio...Starting at €5.74